Jolieke A T van Osch - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jolieke A T van Osch

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Expert Review of Anti-Infective Therapy|July 7, 2025

How frequent is dolutegravir resistance?Jolieke A T van Osch, Thibault Mesplède

The Journal of Antimicrobial Chemotherapy|February 4, 2026

Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failureJolieke A T van Osch, Jolanda J C Voermans, Haajar Ouzerne, et al.

Science Immunology|May 26, 2021

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccineesDaryl Geers, Marc C Shamier, Susanne Bogers, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Expert Review of Anti-Infective Therapy|July 7, 2025

How frequent is dolutegravir resistance?Jolieke A T van Osch, Thibault Mesplède

The Journal of Antimicrobial Chemotherapy|February 4, 2026

Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failureJolieke A T van Osch, Jolanda J C Voermans, Haajar Ouzerne, et al.

Science Immunology|May 26, 2021

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccineesDaryl Geers, Marc C Shamier, Susanne Bogers, et al.

Pageof 1